J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...

A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort ...

A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout ...

Sharp Sterile Manufacturing is investing $28 million to expand equipment at its Lee facility, a move expected to double ...

HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and ...

Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS ...

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

With both companies on an upward trajectory, argenx and its manufacturing partner Fujifilm Biotechnologies are taking a logical next step by expanding their collaboration. In addition to manufacturing ...

Novartis will invest about $70M to build a Florida radioligand therapy plant, expanding its U.S. cancer drug manufacturing ...

RayzeBio’s tiny, radioactive, alpha-emitting isotope is packaged in a vial as an injectable and shipped in a lead container called a “pig.” (Photo courtesy of RayzeBio) New Jersey-based drugmaker ...